| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.032 | 0.8 |